Bio-Techne
TECH
#1479
Rank
C$16.79 B
Marketcap
$105.71
Share price
-0.50%
Change (1 day)
33.25%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): C$1.56 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is C$1.61 Billion. In 2023 the company made a revenue of C$1.51 Billion a decrease over the revenue in the year 2022 that were of C$1.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) C$1.56 B3.25%
2023 C$1.51 B-0.06%
2022 C$1.51 B15.81%
2021 C$1.31 B28.8%
2020 C$1.01 B4.74%
2019 C$0.97 B4.74%
2018 C$0.92 B23.23%
2017 C$0.75 B6.18%
2016 C$0.70 B10%
2015 C$0.64 B36.1%
2014 C$0.47 B34.89%
2013 C$0.35 B13.13%
2012 C$0.31 B-0.38%
2011 C$0.31 B14.42%
2010 C$0.27 B-2.19%
2009 C$0.27 B-14.65%
2008 C$0.32 B37.06%
2007 C$0.23 B-3.39%
2006 C$0.24 B10.73%
2005 C$0.22 B10.22%
2004 C$0.20 B1.49%
2003 C$0.19 B-8.54%
2002 C$0.21 B12.03%
2001 C$0.19 B19.49%
2000 C$0.16 B15.22%
1999 C$0.14 B16.01%
1998 C$0.12 B34.04%
1997 C$90.72 M14.8%
1996 C$79.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$58.93 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.59 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.59 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.87 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.70 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$75.72 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$44.4 M-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA